Praxis Precision Medicines (PRAX) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PRAX Stock Alerts $54.80 +1.92 (+3.63%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMedaptus and Banner Health Partner to Revolutionize Charge Processing with Charge Pro: Beyond Automation to Enhanced Efficiency and Precisiontmcnet.com - April 26 at 11:15 AMAnalysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)markets.businessinsider.com - April 26 at 11:15 AMHC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)marketbeat.com - April 26 at 8:25 AMPraxis Precision Medicines (NASDAQ:PRAX) Sees Strong Trading Volumemarketbeat.com - April 22 at 4:46 PMAnalysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Ironwood Pharma (IRWD)markets.businessinsider.com - April 22 at 1:34 PMWhy an ALS Drug Was Pulled From the Marketmsn.com - April 17 at 10:38 PMPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 2.6%marketbeat.com - April 17 at 11:58 AMPraxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meetingglobenewswire.com - April 12 at 8:00 AMBrokers Offer Predictions for Praxis Precision Medicines, Inc.'s Q2 2024 Earnings (NASDAQ:PRAX)marketbeat.com - April 11 at 7:26 AMPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 2.5% marketbeat.com - April 9 at 11:46 AMPraxis Precision Medicines (NASDAQ:PRAX) Shares Up 5.1%marketbeat.com - April 8 at 2:30 PMPraxis Precision Medicines to Participate in Upcoming April Conferencesglobenewswire.com - April 5 at 9:00 AMPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.1%marketbeat.com - April 3 at 4:22 PMPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 2 at 5:00 PMCitigroup Inc. Grows Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)marketbeat.com - March 31 at 4:06 AMPraxis Precision Medicines Announces Pricing Of Underwritten Public Offeringmarkets.businessinsider.com - March 28 at 6:45 AMPraxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offeringglobenewswire.com - March 28 at 12:20 AMPraxis Precision Medicines, Inc. Announces Proposed Public Offeringglobenewswire.com - March 27 at 4:01 PMPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 3.8% marketbeat.com - March 27 at 12:45 PMPraxis gains after mid-stage data for epilepsy candidatemsn.com - March 26 at 9:28 PMPraxis Precision Medicines Reports Positive Results From PRAX-628 Study - Quick Factsmarkets.businessinsider.com - March 26 at 9:28 PMBuy Rating Affirmed for Praxis Precision Medicines’ PRAX-628 Based on Strong Clinical Trial Outcomes and Market Potentialmarkets.businessinsider.com - March 26 at 9:28 PMWhy Praxis Precision Medicines Stock Is Trading Higher Tuesdaymsn.com - March 26 at 9:28 PMTop 1% Biotech, Praxis, Releases 'Fireworks' And Catapults To Year-Highfinance.yahoo.com - March 26 at 9:28 PMJefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00marketbeat.com - March 26 at 2:28 PMPraxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filingseekingalpha.com - March 26 at 1:34 PMPraxis Precision Medicines (NASDAQ:PRAX) Receives "Buy" Rating from HC Wainwrightmarketbeat.com - March 26 at 12:43 PMPraxis Precision Medicines (NASDAQ:PRAX) Sets New 52-Week High at $66.57marketbeat.com - March 26 at 11:26 AMPraxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patientsglobenewswire.com - March 26 at 6:30 AMPraxis Precision Medicines to Host PRAX-628 Program Updateglobenewswire.com - March 25 at 4:01 PMA Look At The Intrinsic Value Of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)finance.yahoo.com - March 25 at 9:41 AMPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 4.5%marketbeat.com - March 21 at 5:43 PMAnalysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Clene (CLNN) and Jazz Pharmaceuticals (JAZZ)markets.businessinsider.com - March 20 at 1:36 PMPRAX Apr 2024 60.000 callca.finance.yahoo.com - March 19 at 9:34 PMPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Short Interest Updatemarketbeat.com - March 17 at 9:57 AMPRAX May 2024 22.500 callfinance.yahoo.com - March 16 at 12:23 PMAnalysts Are Bullish on These Healthcare Stocks: Allakos (ALLK), Century Therapeutics (IPSC)markets.businessinsider.com - March 15 at 11:20 AMBuy Rating Affirmed for Praxis Precision Medicines Amidst Promising Pipeline and Financial Stabilitymarkets.businessinsider.com - March 11 at 9:27 AMPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Schonfeld Strategic Advisors LLCmarketbeat.com - March 10 at 5:46 AMAdage Capital Partners GP L.L.C. Has $15.01 Million Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)marketbeat.com - March 9 at 6:34 AMEquities Analysts Issue Forecasts for Praxis Precision Medicines, Inc.'s Q1 2024 Earnings (NASDAQ:PRAX)marketbeat.com - March 8 at 6:19 AMPraxis Precision Medicines Inc (PRAX) Reports Full-Year 2023 Financial Results and Corporate Updatesfinance.yahoo.com - March 7 at 4:08 PMAnalysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), InMode (INMD) and Teladoc (TDOC)markets.businessinsider.com - March 7 at 10:43 AMWedbush Analysts Decrease Earnings Estimates for Praxis Precision Medicines, Inc. (NASDAQ:PRAX)marketbeat.com - March 7 at 6:40 AMPraxis Precision Medicines files for $750M mixed shelf offeringmsn.com - March 6 at 6:27 PMPraxis Precision Medicines (NASDAQ:PRAX) Announces Earnings Results, Beats Estimates By $0.08 EPSmarketbeat.com - March 6 at 9:45 AMPraxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 5 at 7:00 AMAcuta Capital Partners LLC Acquires 235,000 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)marketbeat.com - March 3 at 11:58 AMShort Interest in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Declines By 38.1%marketbeat.com - March 2 at 12:40 AMPraxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conferencefinance.yahoo.com - March 1 at 12:35 PM Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> PRAX Media Mentions By Week PRAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.290.33▲Average Medical News Sentiment PRAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼52▲PRAX Articles Average Week Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PureTech Health News Today Pharming Group News Today Savara News Today Nurix Therapeutics News Today Disc Medicine News Today Aurinia Pharmaceuticals News Today Y-mAbs Therapeutics News Today ALX Oncology News Today Bicycle Therapeutics News Today Aerovate Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
